<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:sbol="http://sbols.org/v2#" xmlns:ns0="http://purl.org/dc/terms/" xmlns:ns1="http://wiki.synbiohub.org/wiki/Terms/synbiohub#" xmlns:ns2="http://purl.org/dc/elements/1.1/" xmlns:ns3="http://www.w3.org/ns/prov#" xmlns:ns4="http://purl.obolibrary.org/obo/">
  <sbol:Collection rdf:about="http://examples.org/Collection/sb6b00293/1">
    <ns0:abstract>Transcription activator-like effector nuclease (TALEN) is a programmable genome editing tool with wide applications. Since TALENs perform cleavage of DNA as heterodimers, a pair of TALENs must be synthesized for each target genome locus. Conventionally, TALEN pairs are either expressed on separate vectors or synthesized separately and then subcloned to the same vector. Neither approach allows high-throughput construction of TALEN libraries for large-scale applications. Here we present a single-step assembly scheme to synthesize and express a pair of TALENs in a single-transcript format with the help of a P2A self-cleavage sequence. Furthermore, we developed a fully automated platform to custom manufacture TALENs in a versatile biological foundry. 400 pairs of TALENs can be synthesized with over 96.2% success rate at a material cost of $2.1/pair. This platform opens the door to TALEN-based genome-wide studies.</ns0:abstract>
    <ns1:ownedBy rdf:resource="https://synbioks.org/user/myers"/>
    <ns0:isPartOf rdf:resource="http://pubs.acs.org/journal/asbcd6"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00293_1_sequence/1"/>
    <ns0:created>2017-01-19</ns0:created>
    <ns2:subject>genome engineering</ns2:subject>
    <sbol:version>1</sbol:version>
    <ns1:topLevel rdf:resource="https://synbioks.org/public/ACS/sb6b00293/1"/>
    <ns2:publisher>American Chemical
Society</ns2:publisher>
    <sbol:displayId>sb6b00293</sbol:displayId>
    <ns0:dateCopyrighted>2017</ns0:dateCopyrighted>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00293_1_comp/1"/>
    <ns0:references>Sun, N., Liang, J., Abil, Z., Zhao, H. M. Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease Mol. BioSyst. 2012. 8:1255-1263.</ns0:references>
    <ns0:dateAccepted>2017-01-19</ns0:dateAccepted>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Collection/sb6b00293"/>
    <ns0:dateSubmitted>2016-10-12</ns0:dateSubmitted>
    <ns2:type>research-article</ns2:type>
    <ns4:OBI_0001617>28103009</ns4:OBI_0001617>
    <ns0:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <ns0:rightsHolder>American Chemical Society</ns0:rightsHolder>
    <ns4:OBI_0002110>10.1021/acssynbio.6b00293</ns4:OBI_0002110>
    <ns0:description>Transcription activator-like effector nuclease (TALEN) is a programmable genome editing tool with wide applications. Since TALENs perform cleavage of DNA as heterodimers, a pair of TALENs must be synthesized for each target genome locus. Conventionally, TALEN pairs are either expressed on separate vectors or synthesized separately and then subcloned to the same vector. Neither approach allows high-throughput construction of TALEN libraries for large-scale applications. Here we present a single-step assembly scheme to synthesize and express a pair of TALENs in a single-transcript format with the help of a P2A self-cleavage sequence. Furthermore, we developed a fully automated platform to custom manufacture TALENs in a versatile biological foundry. 400 pairs of TALENs can be synthesized with over 96.2% success rate at a material cost of $2.1/pair. This platform opens the door to TALEN-based genome-wide studies.</ns0:description>
    <ns2:creator>Tong Si</ns2:creator>
    <ns2:rights>Copyright &#169; 2017 American Chemical Society</ns2:rights>
  </sbol:Collection>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00293_1_comp/1">
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00293_1_sequence/1"/>
    <sbol:displayId>sb6b00293_1_comp</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00293_1_comp"/>
    <sbol:version>1</sbol:version>
    <ns3:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00293"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns3:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00293_1_sequence/1">
    <sbol:elements>ggcagcggagctactaacttcagcctgctgaagcaggctggagatgtggaggagaaccctggacctggcatg</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00293_1_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb6b00293_1_sequence</sbol:displayId>
  </sbol:Sequence>
</rdf:RDF>
